Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies
- 30 March 2016
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Dermatological Treatment
- Vol. 27 (5), 473-479
- https://doi.org/10.3109/09546634.2016.1151855
Abstract
The aim of this study is to evaluate four drug regimens for treatment of scabies as regard their efficacy, acceptability and cost effectiveness. Two hundred cases with ordinary scabies were randomized into four groups. First group received ivermectin 200 μg/kg body weight single oral dose, repeated after one week. The second received benzyl benzoate 20% cream. The third received permethrin 2.5%–5% lotion, whereas the fourth group received 5–10% sulfur ointment. Topical treatments were applied for five consecutive nights. Patients were followed up for two weeks for cure rate and adverse effects. At the end of the study, permethrin provided a significant efficacy of 88% and acceptability in 100% of cases, but had higher cost to treat one case (20.25 LE). Ivermectin provided efficacy and acceptability rates of 84% and 96%, respectively, and had a cheaper cost (9.5 LE). Benzyl benzoate provided 80% for both rates and was the cheapest drug. Sulfur ointment provided the least rates, and it was the most expensive. Treatment choice will depend on the age, the general condition of cases, patient compliance to topical treatment and his ability to stick to its roles, and the economic condition of the patient.Keywords
This publication has 33 references indexed in Scilit:
- Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabiesIndian Journal of Dermatology, Venereology and Leprology, 2012
- Skin Disorders, Including Pyoderma, Scabies, and Tinea InfectionsPediatric Clinics of North America, 2009
- Ivermectin worthy of further investigationBulletin of the World Health Organization, 2009
- Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trialBulletin of the World Health Organization, 2009
- Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabiesIndian Journal of Pharmacology, 2009
- Problems in Diagnosing Scabies, a Global Disease in Human and Animal PopulationsClinical Microbiology Reviews, 2007
- Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabiesExpert Opinion on Pharmacotherapy, 2003
- Rapid and Preferential Sebum Secretion of Ivermectin: A New Factor That May Determine Drug Responsiveness in Patients With ScabiesArchives of Dermatology, 2002
- A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabiesJournal of the American Academy of Dermatology, 2000
- A field study of the effects of ivermectin on ectoparasites of manTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991